Perry C. Siatis, EVP, GC AND SECRETARY at AbbVie Inc. (ABBV), sold 45,662 shares at $206.62 ($9.5M) on 2025-02-28, disclosed to the SEC on 2025-03-04.
Scheduled sale ($9.5M) by EVP, GC AND SECRETARY under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $205.02 | 7,870 | $1.6M | 17.0% |
| 2 | $205.38 | 2,718 | $558K | 5.9% |
| 3 | $205.38 | 2,718 | $558K | 5.9% |
| 4 | $206.62 | 6,811 | $1.4M | 14.9% |
| 5 | $206.62 | 6,811 | $1.4M | 14.9% |
| 6 | $207.19 | 363 |
| $75K |
| 0.8% |
| 7 | $207.19 | 363 | $75K | 0.8% |
| 8 | $210.00 | 18,008 | $3.8M | 39.9% |
| Total | $207.54 avg | 45,662 | $9.5M | 100% |
| Filing → |
| ABBV | SELL | 2025-02-24 | $2.3M | — | Filing → |
| ABBV | SELL | 2024-03-01 | $3.5M | — | Filing → |
| ABBV | SELL | 2024-02-27 | $4.9M | — | Filing → |